| scholarly article | Q13442814 |
| P2093 | author name string | Shue-Fen Luo | |
| Joung-Liang Lan | |||
| Hsiao-Yi Lin | |||
| Deh-Ming Chang | |||
| P433 | issue | 11 | |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| placebo | Q269829 | ||
| multicenter clinical trial | Q6934595 | ||
| P304 | page(s) | 2924-2927 | |
| P577 | publication date | 2002-11-01 | |
| P1433 | published in | Arthritis & Rheumatology | Q4797636 |
| P1476 | title | Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trial | |
| P478 | volume | 46 |
| Q38833868 | A critical review of clinical trials in systemic lupus erythematosus |
| Q46905867 | A positive correlation between homocysteine and brachial-ankle pulse wave velocity in patients with systemic lupus erythematosus |
| Q43048441 | A retrospective study of catastrophic invasive fungal infections in patients with systemic lupus erythematosus from southern Taiwan |
| Q35556843 | Androgen therapy with dehydroepiandrosterone |
| Q55357541 | Androgen-Induced Immunosuppression. |
| Q97521616 | Androgen-Mediated Anti-inflammatory Cellular Processes as Therapeutic Targets in Lupus |
| Q46840863 | Association of brachial-ankle pulse wave velocity with cardiovascular risk factors in systemic lupus erythematosus |
| Q37248985 | Autoimmune diseases and reproductive aging |
| Q57458436 | Central intracrine DHEA synthesis in ageing-related neuroinflammation and neurodegeneration: therapeutic potential? |
| Q35968394 | Challenges in bringing the bench to bedside in drug development for SLE. |
| Q56907522 | Chapter 9 Adrenal Involvement in Systemic Autoimmune Diseases |
| Q45086950 | Clinical evaluation of insulin resistance and beta-cell function by the homeostasis model assessment in patients with systemic lupus erythematosus |
| Q43028516 | DHEA, important source of sex steroids in men and even more in women |
| Q38229306 | Dehydroepiandrosterone (DHEA): hypes and hopes. |
| Q37671302 | Dehydroepiandrosterone as a regulator of immune cell function |
| Q24243533 | Dehydroepiandrosterone for systemic lupus erythematosus |
| Q60641092 | Dehydroepiandrosterone in systemic lupus erythematosus |
| Q35553688 | Dehydroepiandrosterone suppresses interleukin 10 synthesis in women with systemic lupus erythematosus. |
| Q35144010 | Dehydroepiandrosterone, a sex steroid metabolite in development for systemic lupus erythematosus |
| Q35553087 | Dehydroepiandrosterone: Is There a Role for Replacement? |
| Q79222791 | Effect of dehydroepiandrosterone on cartilage and synovium of knee joints with osteoarthritis in rabbits |
| Q46864446 | Effects of dehydroepiandrosterone supplement on health-related quality of life in glucocorticoid treated female patients with systemic lupus erythematosus |
| Q43041708 | Effects of prasterone (dehydroepiandrosterone) on markers of cardiovascular risk and bone turnover in premenopausal women with systemic lupus erythematosus: a pilot study |
| Q46226045 | Elevation of fasting insulin and its association with cardiovascular disease risk in women with systemic lupus erythematosus |
| Q51498308 | Elevation of plasma interleukin-18 concentration is associated with insulin levels in patients with systemic lupus erythematosus. |
| Q36634248 | Emerging drug therapies for systemic lupus erythematosus |
| Q79211140 | Enhanced oxidative status but not corresponding elevated antioxidative status by anticardiolipin antibody and disease activity in patients with systemic lupus erythematosus |
| Q28385351 | Environmental exposures and the development of systemic lupus erythematosus |
| Q44254629 | Fatigue in patients with systemic lupus erythematosus: the role of dehydroepiandrosterone sulphate |
| Q34040802 | Gender differences in autoimmune disease |
| Q38883883 | Immunomodulators in SLE: Clinical evidence and immunologic actions |
| Q51560916 | Late onset lupus nephritis: analysis of clinical manifestations and renal pathological features in Chinese patients. |
| Q35925513 | Lupus nephritis: a review of the current pharmacological treatments |
| Q37754815 | Management of systemic lupus erythematosus in Chinese patients |
| Q92625510 | Management strategies and future directions for systemic lupus erythematosus in adults |
| Q37914899 | Measuring outcomes in systemic lupus erythematosus clinical trials |
| Q64283956 | Mechanisms of hypertension in autoimmune rheumatic diseases |
| Q36760284 | Might DHEA be considered a beneficial replacement therapy in the elderly? |
| Q51029067 | New insights into the protective effects of DHEA1). |
| Q35148630 | Novel Approaches to Therapy for SLE. |
| Q37754557 | Novel approaches to therapy for systemic lupus erythematosus: update 2005. |
| Q34351248 | Optimal management of fatigue in patients with systemic lupus erythematosus: a systematic review |
| Q33664927 | Pathogenesis of human systemic lupus erythematosus: recent advances |
| Q44299617 | Patients with refractory Crohn's disease or ulcerative colitis respond to dehydroepiandrosterone: a pilot study |
| Q35560451 | Pharmacology And Therapeutic Effects of Dehydroepiandrosterone In Older Subjects |
| Q37510905 | Pharmacotherapy of systemic lupus erythematosus. |
| Q45034864 | Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sjögren's syndrome |
| Q35554324 | Possible role of leptin in hypoandrogenicity in patients with systemic lupus erythematosus and rheumatoid arthritis |
| Q36647608 | Prasterone |
| Q35554437 | Renal clearance and daily excretion of cortisol and adrenal androgens in patients with rheumatoid arthritis and systemic lupus erythematosus. |
| Q50848358 | Systemic lupus erythematosus. |
| Q46686656 | Systemic lupus erythematosus: clinical manifestations, treatment and economics |
| Q26795584 | The influence of endogenous and exogenous sex hormones on systemic lupus erythematosus in pre- and postmenopausal women |
| Q40568409 | The role of plasmapheresis in the treatment of severe central nervous system neuropsychiatric systemic lupus erythematosus |
| Q37581232 | Understanding how we age: insights into inflammaging |
| Q37690745 | Update on emerging drug therapies for systemic lupus erythematosus |
| Q37504605 | Updated review of complementary and alternative medicine treatments for systemic lupus erythematosus |
Search more.